Study of a New Dressing for Use With Topical Medications
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00234728|
Recruitment Status : Completed
First Posted : October 7, 2005
Last Update Posted : July 2, 2008
|Condition or disease||Intervention/treatment||Phase|
|Psoriasis||Device: Occlusive dressing||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||120 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||An Open-Label, Bilaterally-Controlled Single Center Study to Compare the Efficacy of Occlusion of Topical Agents With a Hydrophilic Occlusive Dressing to Treatment With Occlusive Dressing Without the Addition of Topical Agents|
|Study Start Date :||September 2005|
|Actual Study Completion Date :||June 2007|
- Efficacy of topical medications with new occlusive dressing at baseline, weeks 2, 4, 6, 8.
- Efficacy with new occlusive dressing alone without topical medications at baseline, weeks 2, 4, 6, 8.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00234728
|United States, California|
|UCSF Psoriasis and Skin Treatment Center|
|San Francisco, California, United States, 94118|
|Principal Investigator:||John Koo, MD||University of California, San Francisco|